STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

90 hedge funds and large institutions have $337M invested in Stemline Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

94% less call options, than puts

Call options by funds: $254K | Put options by funds: $4.08M

Holders
90
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$254K
Puts
$4.08M
Net Calls
Net Calls Change

Top Buyers

1 +$4.18M
2 +$2.35M
3 +$1.94M
4
Invesco
Invesco
Georgia
+$1.93M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.33M

Top Sellers

1 -$7.47M
2 -$7.3M
3 -$2.41M
4
Two Sigma Investments
Two Sigma Investments
New York
-$2.05M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.52M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$45.6M
2
$34.1M
3
$32.7M
4
$25.8M
5
$24.1M
6
$21.2M
7
$18M
8
$15M
9
$14.9M
10
$11.8M
11
$9.66M
12
$7.5M
13
$7.46M
14
$6.64M
15
$6.61M
16
$4.66M
17
$4.32M
18
$4.18M
19
$2.98M
20
$2.84M
21
$2.46M
22
$2.27M
23
$1.93M
24
$1.77M
25
$1.75M